1. Home
  2. PCVX vs THG Comparison

PCVX vs THG Comparison

Compare PCVX & THG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • THG
  • Stock Information
  • Founded
  • PCVX 2013
  • THG 1852
  • Country
  • PCVX United States
  • THG United States
  • Employees
  • PCVX N/A
  • THG N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • THG Property-Casualty Insurers
  • Sector
  • PCVX Health Care
  • THG Finance
  • Exchange
  • PCVX Nasdaq
  • THG Nasdaq
  • Market Cap
  • PCVX 6.0B
  • THG 6.3B
  • IPO Year
  • PCVX 2020
  • THG 1995
  • Fundamental
  • Price
  • PCVX $49.03
  • THG $181.66
  • Analyst Decision
  • PCVX Strong Buy
  • THG Buy
  • Analyst Count
  • PCVX 7
  • THG 7
  • Target Price
  • PCVX $101.67
  • THG $190.86
  • AVG Volume (30 Days)
  • PCVX 1.3M
  • THG 201.4K
  • Earning Date
  • PCVX 11-04-2025
  • THG 10-29-2025
  • Dividend Yield
  • PCVX N/A
  • THG 1.98%
  • EPS Growth
  • PCVX N/A
  • THG 73.14
  • EPS
  • PCVX N/A
  • THG 17.31
  • Revenue
  • PCVX N/A
  • THG $6,506,900,000.00
  • Revenue This Year
  • PCVX N/A
  • THG $4.03
  • Revenue Next Year
  • PCVX N/A
  • THG $5.61
  • P/E Ratio
  • PCVX N/A
  • THG $10.48
  • Revenue Growth
  • PCVX N/A
  • THG 5.26
  • 52 Week Low
  • PCVX $27.66
  • THG $145.17
  • 52 Week High
  • PCVX $98.17
  • THG $186.46
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 69.14
  • THG 61.95
  • Support Level
  • PCVX $40.14
  • THG $176.52
  • Resistance Level
  • PCVX $45.90
  • THG $184.09
  • Average True Range (ATR)
  • PCVX 2.30
  • THG 3.46
  • MACD
  • PCVX 0.26
  • THG 1.16
  • Stochastic Oscillator
  • PCVX 91.15
  • THG 85.40

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business internationally through a wholly owned subsidiary, Chaucer Holdings Limited, domiciled in the United Kingdom. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

Share on Social Networks: